S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 80 800 KRW 4.53% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 116 022.72 KRW. Compared to the current market price of 80 800 KRW, ST Pharm Co Ltd is Undervalued by 30%.

Intrinsic Value
116 022.72 KRW
Undervaluation 30%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
ST Pharm Co Ltd

Valuation History Unavailable

Historical valuation for ST Pharm Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
Compare ST Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ST Pharm Co Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about ST Pharm Co Ltd

Provide an overview of the primary business activities
of ST Pharm Co Ltd.

What unique competitive advantages
does ST Pharm Co Ltd hold over its rivals?

What risks and challenges
does ST Pharm Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ST Pharm Co Ltd.

Provide P/S
for ST Pharm Co Ltd.

Provide P/E
for ST Pharm Co Ltd.

Provide P/OCF
for ST Pharm Co Ltd.

Provide P/FCFE
for ST Pharm Co Ltd.

Provide P/B
for ST Pharm Co Ltd.

Provide EV/S
for ST Pharm Co Ltd.

Provide EV/GP
for ST Pharm Co Ltd.

Provide EV/EBITDA
for ST Pharm Co Ltd.

Provide EV/EBIT
for ST Pharm Co Ltd.

Provide EV/OCF
for ST Pharm Co Ltd.

Provide EV/FCFF
for ST Pharm Co Ltd.

Provide EV/IC
for ST Pharm Co Ltd.

Show me price targets
for ST Pharm Co Ltd made by professional analysts.

What are the Revenue projections
for ST Pharm Co Ltd?

How accurate were the past Revenue estimates
for ST Pharm Co Ltd?

What are the Net Income projections
for ST Pharm Co Ltd?

How accurate were the past Net Income estimates
for ST Pharm Co Ltd?

What are the EPS projections
for ST Pharm Co Ltd?

How accurate were the past EPS estimates
for ST Pharm Co Ltd?

What are the EBIT projections
for ST Pharm Co Ltd?

How accurate were the past EBIT estimates
for ST Pharm Co Ltd?

Compare the revenue forecasts
for ST Pharm Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of ST Pharm Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ST Pharm Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of ST Pharm Co Ltd compared to its peers.

Compare the P/E ratios
of ST Pharm Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing ST Pharm Co Ltd with its peers.

Analyze the financial leverage
of ST Pharm Co Ltd compared to its main competitors.

Show all profitability ratios
for ST Pharm Co Ltd.

Provide ROE
for ST Pharm Co Ltd.

Provide ROA
for ST Pharm Co Ltd.

Provide ROIC
for ST Pharm Co Ltd.

Provide ROCE
for ST Pharm Co Ltd.

Provide Gross Margin
for ST Pharm Co Ltd.

Provide Operating Margin
for ST Pharm Co Ltd.

Provide Net Margin
for ST Pharm Co Ltd.

Provide FCF Margin
for ST Pharm Co Ltd.

Show all solvency ratios
for ST Pharm Co Ltd.

Provide D/E Ratio
for ST Pharm Co Ltd.

Provide D/A Ratio
for ST Pharm Co Ltd.

Provide Interest Coverage Ratio
for ST Pharm Co Ltd.

Provide Altman Z-Score Ratio
for ST Pharm Co Ltd.

Provide Quick Ratio
for ST Pharm Co Ltd.

Provide Current Ratio
for ST Pharm Co Ltd.

Provide Cash Ratio
for ST Pharm Co Ltd.

What is the historical Revenue growth
over the last 5 years for ST Pharm Co Ltd?

What is the historical Net Income growth
over the last 5 years for ST Pharm Co Ltd?

What is the current Free Cash Flow
of ST Pharm Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for ST Pharm Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
ST Pharm Co Ltd

Current Assets 330.1B
Cash & Short-Term Investments 120.9B
Receivables 70B
Other Current Assets 139.2B
Non-Current Assets 391.8B
Long-Term Investments 23.4B
PP&E 338.7B
Intangibles 16.5B
Other Non-Current Assets 13.2B
Current Liabilities 133.3B
Accounts Payable 10.6B
Accrued Liabilities 1.6B
Short-Term Debt 30B
Other Current Liabilities 91B
Non-Current Liabilities 85.5B
Long-Term Debt 44.8B
Other Non-Current Liabilities 40.7B
Efficiency

Free Cash Flow Analysis
ST Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
ST Pharm Co Ltd

Revenue
274.4B KRW
Cost of Revenue
-178B KRW
Gross Profit
96.4B KRW
Operating Expenses
-69.6B KRW
Operating Income
26.8B KRW
Other Expenses
2.7B KRW
Net Income
29.5B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

ST Pharm Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
ROE is Increasing
46/100
Profitability
Score

ST Pharm Co Ltd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

ST Pharm Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
88/100
Solvency
Score

ST Pharm Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
ST Pharm Co Ltd

Wall Street analysts forecast ST Pharm Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ST Pharm Co Ltd is 116 025 KRW with a low forecast of 101 000 KRW and a high forecast of 136 500 KRW.

Lowest
Price Target
101 000 KRW
25% Upside
Average
Price Target
116 025 KRW
44% Upside
Highest
Price Target
136 500 KRW
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for ST Pharm Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ST Pharm Co Ltd stock?

The intrinsic value of one ST Pharm Co Ltd stock under the Base Case scenario is 116 022.72 KRW.

Is ST Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 80 800 KRW, ST Pharm Co Ltd is Undervalued by 30%.

Back to Top